DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people ...

Four years ago, my life changed after a heart attack at the age of 33. While a quick coronary angioplasty meant my heart was mostly fine, the tests conducted at the same time revealed a bigger chronic ...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 ...

DexCom (DXCM) is under the spotlight after several class action lawsuits were filed claiming the company made unauthorized changes to its G6 and G7 glucose monitoring devices. These changes could ...

Continuous glucose monitoring (CGM) tracks glucose levels every 1 to 5 minutes, helping people with diabetes understand how food, sleep, and exercise affect their blood sugar without frequent ...

April 28, 2006 — The US Food and Drug Administration (FDA) has approved a liquid-based Papanicolaou test system for use in collecting and preparing cervical/vaginal specimens; a continuous monitoring ...